Global Serological Testing Market – Industry Trends and Forecast to 2030

Análise e dimensão do mercado de testes serológicos

Em 2019, de acordo com os Centros de Controlo e Prevenção de Doenças, foram registados aproximadamente 34.800 novos casos de VIH nos EUA. Algumas das aplicações mais vitais para as soluções e produtos que os participantes do mercado desenvolvem incluem infeções por rotavírus, monitorização de medicamentos terapêuticos, VIH, hepatite, endotoxinas e outras doenças infeciosas .

A Data Bridge Market Research analisa que o mercado de testes serológicos deverá atingir os 7,6 mil milhões de dólares até 2030, o que equivale a 4,52 mil milhões de dólares em 2022, e deverá passar por um CAGR de 6,70% durante o período de previsão de 2023 a 2030. Além do conhecimento sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análise especializada aprofundada, epidemiologia de doentes, análise de pipeline, análise de preços e enquadramento regulamentar.

Âmbito e segmentação do mercado de testes serológicos

Definição de mercado

Os testes serológicos são utilizados para identificar anticorpos ou antigénios. Quando o organismo entra em contacto com um antigénio, o sistema imunitário liberta anticorpos como mecanismo de defesa e tenta normalizar o antigénio. Nos testes serológicos, estes antigénios e anticorpos são validados para o diagnóstico de uma doença e condição específica que ajuda ainda mais os médicos a administrar o tratamento médico adequado. O teste serológico é feito por vários métodos, como ensaios imunoenzimáticos (ELISAs), testes de inibição da hemaglutinina, testes de floculação, imunoensaios de quimioluminescência e testes de neutralização.

Dinâmica do mercado de testes serológicos

Motoristas

• Aumento do uso de imunoensaio de quimioluminescência

O mercado está a assistir a uma grande mudança em relação ao método ELISA tradicional e a avançar para a utilização do CLIA. As complicações da doença aumentaram a necessidade de detetar moléculas-alvo mais pequenas, o que leva ao aparecimento da CLIA. É utilizado em combinação com um antigénio de marcação direta (anticorpo) e um indicador como o isoluminol, o luminol ou um éster de acridínio. Prevê-se que a crescente sensibilidade e precisão do imunoensaio de quimioluminescência sobre o ensaio imunoenzimático (ELISA) impulsione o crescimento do mercado.

• Aumento do teste de anticorpos

O teste de anticorpos contribui para o crescimento do mercado. Este domínio deve-se aos benefícios dos testes de anticorpos e aos vários avanços na testagem do vírus serológico. A elevada procura por outros testes, como testes de carga viral e testes de genótipo, vai aumentar no período de previsão devido às melhorias e precisões dos testes e à adoção por profissionais especializados.

Oportunidades

• Procura crescente de ELISA

O ELISA é de grande procura e lidera o mercado devido ao menor tempo de resposta para testes, longa vida útil dos regentes, reagentes baratos e acessíveis, um grande número de exames de doenças infecciosas, alta especificidade, alta sensibilidade e analisadores ELISA são baratos. Além disso, o avanço tecnológico, as etapas menos complexas necessárias para a execução, a triagem de alta precisão e vários participantes importantes estão a contribuir para o crescimento do segmento de testes ELISA.

• Aumento da incidência de tuberculose

There has been increasing incidence of TB in the recent years that lead to the growth of the serological testing. India's TB incidence for the year 2021 is 210 per 100,000 population than the baseline year of 2015. The incidence was 256 per lakh of population in India and there has been an 18% deterioration. TB is the 13th leading cause of death worldwide and the second leading cause of infectious killer after COVID-19.

Restraints/Challenges

• High cost of Diagnostic Tests

There has been numerous tests that are hugely available for testing hepatitis diseases. But these tests are of increasing cost that is not afforded by numerous patients, mainly belonging to the lower economic groups. Thus, it hampers the market growth.

This serological testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the serological testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2021, Seimens and Hemogenomics made a clinical trial to do an extensive evaluation of the ADVIA Centaur XP chemiluminescence system.
• In 2019, Mylab Disocovery Solutions launched NATSpert, which is used to screen HIV, HBV, HCV in donated blood.

Global Serological Testing Market Scope

The serological testing market is segmented on the basis of test type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Primary Serological Tests
• Enzyme Linked Immunosorbent Assay (ELISA)
• Immunoflurescent Antibody Technique (IFAT)
• Radio Immunoassay (RIA)
• Secondary Serological Tests
• Agglutination Tests
• Complement Fixation Tests (CFT)
• Precipitation Tests
• Serum Neutralization Tests (SNT)
• Toxin-antitoxin Tests
• Tertiary Binding Tests

Application

• Rotavirus Infections
• Hepatitis
• HIV
• Endotoxins
• Therapeutic Drug Monitoring
• Other Infectious Diseases

End-user

• Hospital and Clinics
• Diagnostic Laboratories
• Blood Banks
• Diagnostic Laboratories
• Others

Serological Testing Regional Analysis/Insights

The serological testing market is analyzed and market size insights and trends are provided by test type, application and end-user as referenced above.

The countries covered in the serological testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the serological testing market due to the increasing incidence of infectious diseases, well-established health care infrastructure and rise in number of geriatric population in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the increase in awareness, and rise in per capita health care expenditure along with huge rate of infectious diseases in developing countries such as India and China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The serological testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for serological testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the serological testing market. The data is available for historic period 2011-2021.

Competitive Landscape and Global Serological Testing Market Share Analysis

The serological testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to serological testing market.

Some of the major players operating in the serological testing market are:

• Serological Research Institute (SERI) (U.K.)
• Chembio Diagnostics, Inc (U.S.)
• Cellex (U.S.)
• Randox Laboratories Ltd (U.K.)
•  Abbott (U.S.)
• Bio-Rad Laboratories Inc. (U.S.)
• BD (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Ortho Clinical Diagnostics (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Abcam Plc (U.K.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• ELITechGroup (France)
• Teleflex Incorporated (U.S.)
• Grifols, S.A. (U.S.)
• Global Scientific Company (India)
• Beckman Coulter, Inc. (U.S.)
• BIOMEDOMICS INC. (U.S.)
• Creative Diagnostics (U.S.)

SKU-57082